Back to Article

Clinical differences between hospitalized patients with COVID-19-related pneumonia and those with influenza-related pneumonia during the omicron variant surge

Global Journal of Epidemiology and Infectious Disease | Vol 4, Issue 1

Table 1. Patients’ background characteristics by group

COVID-19 pneumoniaFlu pneumoniap value
Patients number46 (46/285 =15.5%) 6 (6/12=50.0%)0.002**
Male/Female33/13 (Male :71.7%)5/1 (Male:83.3%)0.547
Age, years old75.5 (45-93) 53.8 (19-73)0.002**
Underlying diseases
Diabetes mellitus7 (15.2%)3 (50.0%)0.042*
Solid malignant tumor 6 (13.0%)00.3469
Brain stroke6 (13.0%)1 (1.7%)0.806
Dementia5 (10.9%)1 (1.7%)0.676
Heart diseases4 (8.7%)1 (1.7%)0.533
Neurological diseases4 (8.7%)00.452
Mental disorders2 (4.3%)00.602
Hematological diseases2 (4.3%)1 (1.7%)0.543
AIDS1 (2.2%)00.715
Rheumatoid arthritis1 (2.2%)00.715
Chronic lung diseases1 (2.2%)1 (1.7%)0.259
Kidney diseases1 (2.2%)00.715
Infection route
Clusters (Facilities)9 (19.6%)00.233
Inpatients5 (10.9%)2 (33.3%)0.129
Nursing visit service4 (8.7%)00.452
Home4 (8.7%)1 (16.7%)0.533
Work2 (4.3%)2 (33.3%)0.012*
Unknown22 (47.8%)1 (16.7%)0.148
Vaccination
5 times<4 (8.7%)NA
4 times5 (10.9%)NA
3 times6 (13.0%)NA
Twice7 (15.2%)NA
Once02 (33.3%)0.304
None8 (17.3%)4 (66.7%)0.007**
 Unknown16 (34.8%)00.008